Entering text into the input field will update the search result below

Coherus BioSciences' (CHRS) CEO Dennis Lanfear on Q4 2017 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Coherus BioSciences (NASDAQ:CHRS) Q4 2017 Results Earnings Conference Call March 8, 2018 4:30 PM ET


Patrick O'Brien - SVP of IR

Dennis Lanfear - President, CEO and Chairman

Barbara Finck - Chief Medical Officer

Jean-Frédéric Viret - CFO

Matt Hooper - EVP and General Counsel

Michael Fleming - EVP of Sales and Marketing


Steve Seedhouse - BMO Capital Markets

Alethia Young - Credit Suisse

Christopher Neyor - JPMorgan

Mohit Bansal - Citigroup

Douglas Tsao - Barclays


Ladies and gentlemen, thank you for standing by, and welcome to the Coherus BioSciences Fourth Quarter Earnings Conference Call. My name is Mike, and I will be your conference operator for the call today. At this time, all participants are in a listen-only mode. And as a reminder, this conference call is being recorded.

I would now like to turn the call over to Patrick O'Brien, Senior Vice President of Investor Relations. Please go ahead.

Patrick O'Brien

Thank you, Mike, and good afternoon, everyone. After close of market today, we issued a fourth quarter financial results press release. This release can be found on the Coherus BioSciences' website.

Joining me for today's call will be Dennis Lanfear, President and CEO and Chairman; Barbara Finck, Chief Medical Officer; Jean Viret, CFO; Matt Hooper, EVP and General Counsel; and Michael Fleming, EVP of Sales and Marketing.

Before we begin our formal remarks, I'd like to remind you that we will be making forward-looking statements with respect to product development plans, all of which involve certain assumptions, risks and uncertainties that are beyond our control and could cause actual results to differ from these statements. A description of these risks can be found on our most recent Form 10-K which we filed this afternoon after market close. In addition, Coherus BioSciences does not undertake any obligation to update any forward-looking

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.